Upsher-Smith Pharma ceuticals Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Upsher-Smith Pharma ceuticals Inc

Sort by

Viewing results 1‒25 of 60

FT News Briefing podcast10 min listen
US sues to block drug merger
...The show’s editor is Jess Smith. Additional help by Katie McMurran, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer....
May 17, 2023
AstraZeneca PLC
AstraZeneca chair says it is paying CEO enough to ward off US rivals
...The UK pharma industry has previously lost executives over pay....
May 4, 2023
Unilever PLC
GSK rejects Unilever’s £50bn offer for consumer unit
...Walmsley plans to use proceeds from the spin-off to bolster the pharma and drugs business’ lacklustre pipeline....
January 15, 2022
Due Diligence
The law firm that perfected the Texas two-step Premium content
...(Bloomberg) Open to suggestion Activists swarming corporate Japan have found an ally in Tokyo Stock Exchange boss Hiromi Yamaji, who says more vocal investors could be exactly what Japan Inc needs....
February 8, 2022
News in-depthCovid-19 vaccines
After 33 years of failure, Novavax closes in on Covid triumph
...It still has its doubters, with about a 10 per cent short interest placing it in the top five pharma or biotech shorts by value, according to S3 Partners....
March 1, 2021
FT SeriesCompanies prospering in the pandemic
Pharma industry seizes on pandemic as a shot at redemption
...The lockdowns imposed to contain the virus are likely to have hit sales of drugs that need a doctor to administer them, while the delay in non-essential surgeries has hurt others including Smith & Nephew...
July 6, 2020
FirstFT
FirstFT: Today’s top stories
...The US administration has committed to spending $1.95bn on 100m doses of a potential Covid-19 vaccine being developed by Germany’s BioNTech and US pharma giant Pfizer....
July 22, 2020
IPOs
US grocer Albertsons scales back stock market listing
...This month Royalty Pharma sold $2.2bn of stock and Warner Music raised $1.9bn in the two biggest deals of the year....
June 25, 2020
Due Diligence
SoftBank and Benchmark square off over WeWork Premium content
...Online education start-up Yuanfudao led the way with a $1bn raise from investors that included Chinese technology company Tencent, while biotech and pharma emerged as the most popular sector....
April 15, 2020
Due Diligence
Inside the firm that leased 666 Fifth Avenue from the Kushners Premium content
...If you understand the law, it pays to be stubborn, writes the FT’s Rob Smith. (FT) What’s in a name?...
February 6, 2020
Due Diligence
IPOs postponed and debt offerings shelved. Coronavirus-induced volatility is gumming up critical sources of capital Premium content
...Chris Hite, Citigroup’s top healthcare dealmaker, is leaving the US bank to join Royalty Pharma, Bloomberg reported. WeWork has named former Baker Hughes executive Kimberly Ross as its CFO....
March 4, 2020
News in-depthFT Alphaville
Inside BenevolentAI: the $2bn tech company backed by Neil Woodford
...As you can see above, Upsher-Smith sold its entire position between autumn 2017 to 2018....
June 18, 2019
News in-depthThe Big Read
Can we ever trust Google with our health data?
...Sam Smith, a privacy activist at Med Confidential, says the question is whether consumers are happy with a big company like Google, Facebook or Amazon doing everything....
January 20, 2020
Drugs research
GSK market hopes boosted by two-drug HIV trial
...Separately, Merck, the US pharma group, announced results from an early trial for a new treatment for HIV at the conference....
July 24, 2019
FT AlphavilleIPOs
Guess the company, Howard Marks edition
...This can only be Avantor, whose debt-funded takeover of much larger publicly traded peer VWR saw the pharma group take on eye-watering leverage to pay $1.4bn of dividends to New Mountain Capital....
October 2, 2018
News in-depthPharmaceuticals sector
Investors smart at ailing pharma deals
...Scott Smith, who had been promoted from head of its inflammation and immunology unit, stepped down as chief operating officer and president on Monday....
April 4, 2018
Special ReportWomen in Technology
AI startup boss Jackie Hunter upends pharma and male tech culture
...She had worked for him before, as a non-executive director at Proximagen, a biotech company Mr Mulvany sold to drugmaker Smith Upsher in 2012....
March 9, 2018
The Big ReadJapanese business & finance
Why Japan Inc is gambling on M&A growth
...Last year, the Osaka-based drugmaker completed a $1.1bn acquisition of the generic drug business of US-based Upsher-Smith Laboratories, its first overseas purchase....
April 30, 2018
Financial services
When Silicon Valley came to Wall Street
...Gilead Sciences recently reached an $11.9bn agreement to acquire Kite Pharma for a 50 per cent premium to its monthly average stock price....
October 28, 2017
Pharmaceuticals sector
Mitsubishi Tanabe to pay $1.1bn for Israeli drugmaker
...third-biggest outbound Japanese drug acquisition this year behind Takeda Pharmaceuticals’ $5.2bn purchase in January of Boston-based cancer drugmaker Ariad, and Sawai Pharmaceuticals buying generics maker Upsher-Smith...
July 24, 2017
US & Canadian companies
Pfizer fined £84m for charging ‘unfair’ price for epilepsy drug
...Pharma companies were under the spotlight over pricing during the US presidential campaign, partly after Martin Shkreli, the “bad boy” of pharma, raised the price of a life-saving cancer and Aids drug from...
December 7, 2016
US & Canadian companies
Week in Review, September 26
...Drug price scandal alters outlook for biotech groups Tens of billions of dollars were wiped off the value of biotech and pharmaceuticals companies this week after Hillary Clinton pledged to tackle “profiteering...
September 25, 2015
US & Canadian companies
FDA performs U-turn over restriction of pain drug
...James Beck, an attorney at Reed Smith, described the FDA’s U-turn as “remarkable” and said he could not recall a previous occasion when the agency had rescinded a warning letter....
December 15, 2015
InterviewEuropean companies
Olivier Bohuon insists Smith & Nephew can prosper on its own
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
October 11, 2015
The Monday Interview
The Botox initiation of Brent Saunders, Actavis chief executive
...The chief executive of pharmaceuticals company Actavis had taken to the stage to address the salesforce at Allergan, one of his first big outings after his group had said it would buy the maker of injectable...
May 17, 2015

Previous pagePage 1 of 3Next page